NRX Pharmaceuticals Q4 EPS $(0.05) Beats $(0.07) Estimate

benzinga_article
2024.03.29 03:34

NRX Pharmaceuticals（纳斯达克股票代码：NRXP）报告每股亏损为$(0.05)，超过分析师共识预期的$(0.07)，增幅达 28.57%。与去年同期每股亏损$(0.16) 相比，亏损增长了 68.75%

NRX 制药公司（NASDAQ 股票代码：NRXP）报告每股亏损 0.05 美元，超过分析师预期的每股亏损 0.07 美元，增幅达 28.57%。这比去年同期每股亏损 0.16 美元增长了 68.75%

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.